Cargando…
Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy
SIMPLE SUMMARY: Cancer therapy has evolved over the years, immunotherapy being the most used for untreatable malignant tumors. Immune checkpoint inhibitors decrease the ability of tumor cells to escape the immune system. Although immune checkpoint inhibitors have a significant impact in the treatmen...
Autores principales: | Bobircă, Anca, Bobircă, Florin, Ancuta, Ioan, Florescu, Alesandra, Pădureanu, Vlad, Florescu, Dan Nicolae, Pădureanu, Rodica, Florescu, Anca, Mușetescu, Anca Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235766/ https://www.ncbi.nlm.nih.gov/pubmed/34203101 http://dx.doi.org/10.3390/biology10060561 |
Ejemplares similares
-
The Role of Clinical and Ultrasound Enthesitis Scores in Ankylosing Spondylitis
por: Florescu, Alesandra, et al.
Publicado: (2021) -
Polymyalgia rheumatica: An update (Review)
por: Florescu, Mirela Marinela, et al.
Publicado: (2023) -
COVID-19—A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis
por: Bobircă, Anca, et al.
Publicado: (2022) -
Novel Biomarkers, Diagnostic and Therapeutic Approach in Rheumatoid Arthritis Interstitial Lung Disease—A Narrative Review
por: Florescu, Alesandra, et al.
Publicado: (2022) -
Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
por: Bobirca, Anca, et al.
Publicado: (2022)